Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX), Eli Lilly & Co (LLY) and Teva Pharmaceutical (TEVA)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immuneering (IMRX – Research Report), Eli Lilly & Co (LLY – Research Report) and Teva Pharmaceutical (TEVA – Research Report) with bullish sentiments.

In a report issued on August 1, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Immuneering. The company’s shares closed last Friday at $1.33, close to its 52-week low of $1.05.

According to TipRanks.com, Suvannavejh is a 1-star analyst with an average return of -2.0% and a 48.2% success rate. Suvannavejh covers the Healthcare sector, focusing on stocks such as Cerevel Therapeutics Holdings, Harmony Biosciences Holdings, and Amylyx Pharmaceuticals Inc.